IL10 and prostate carcinoma: For example, Carlson et al. (2003) and Witek-Janusek et al. (2008) both reported decreases in the anti-inflammatory IL-10 in breast and prostate cancer patients following MBSR, which might reflect a healthy improvement given baseline stress-induced immune dysregulation in this population (Witek-Janusek et al., 2007).